Skip to main content
The American Journal of Tropical Medicine and Hygiene logoLink to The American Journal of Tropical Medicine and Hygiene
. 2017 Jan 11;96(1):88–92. doi: 10.4269/ajtmh.15-0702

Seroepidemiology of Human Brucellosis Among Blood Donors in Southern Ethiopia: Calling Attention to a Neglected Zoonotic Disease

Bereket Workalemahu 1,*, Tsegaye Sewunet 2, Ayalew Astatkie 3
PMCID: PMC5239715  PMID: 28077743

Abstract

Human brucellosis is neglected in southern Ethiopia. Although traditional food processing practices and animal husbandry which increase the risk of brucellosis are common, it has not been properly studied yet. This study was conducted to determine the seroepidemiology of brucellosis among apparently healthy individuals in southern Ethiopia. In the study, blood samples were collected to screen for serum agglutinins reactive to stained antigen of Brucella abortus. Standard tube titration was performed for reactive serum to determine the titer of the agglutinin. A structured questionnaire was used to collect data on possible risk factors for brucellosis. The seroprevalence of human brucellosis in this study was found to be 10.6% (95% confidence interval = 7.0, 14.0). Possession of domestic ruminant animals, contact with ruminant animals, and husbandry practices at home were associated with seropositivity. The higher seroprevalence of human brucellosis in the study area needs attention and additional confirmatory investigation.


Human brucellosis is one of the most common zoonotic diseases worldwide and remains endemic in areas like Europe, northern and eastern Africa, India, central Asia, Mexico, and Central and South America.1 Although eradicated in many developed countries, brucellosis remains a major neglected zoonotic disease in low-income countries and a concern of reemergence in many countries with an increasing incidence of infection in cattle.2 Both Food and Agriculture Organization and the World Health Organization considered brucellosis as one of the most widely spread zoonoses in the world.3 Annual incidence of human brucellosis may range from a few cases to more than 500 cases per 1,000,000 populations in different parts of the world. A global report estimated human cases to be 500,000 each year.1 These figures, however, are more likely an underestimate of the true disease burden due to nonspecific clinical cases in many endemic countries where health systems are weak and misdiagnoses of cases are common.4 In Ethiopia, the burden of human brucellosis remains unclear and epidemiological data on the disease remain scarce.5

Humans acquire the infection mainly through contact with an infected animal and consumption of fresh unprocessed animal products. Other possible means of acquisition of brucellosis include person-to-person transmission (blood donation, tissue transplantation, etc.) and infection from a contaminated environment.6 Brucellosis is also an occupational hazard of livestock farmers, dairy workers, veterinarians, slaughterhouse workers, and laboratory personnel.7,8 Human infection may involve many organ systems and the disease usually manifests itself as an acute febrile illness characterized by a multitude of somatic complaints and nonspecific symptoms (fever, sweating, anorexia, malaise, weight loss, depression, headache, and arthralgia), and is easily confused with a wide spectrum of infectious and noninfectious diseases. The disease may persist and progress to a chronically incapacitating disease with severe complications like bone and joint involvement, neurobrucellosis, endocarditis, and epididymo-orchitis. Nevertheless, brucellosis is rarely fatal in humans with an estimated mortality rate of less than 2%.5,6,9 The disease is also an important cause of travel-associated morbidity.1

The causative agents of brucellosis are small Gram-negative intracellular coccobacillary organisms that have predilection to host species. In addition to the better-known six classical species of Brucella (Brucella abortus, Brucella melitensis, Brucella suis, Brucella ovis, Brucella canis, and Brucella neotomae), newer members of the genus include Brucella ceti, Brucella pinnipedialis, Brucella microti, and Brucella inopinata. Of these species, B. melitensis poses the greatest risk for human infection followed by B. suis and B. abortus. However, other species have also been shown to be virulent for humans infected.5,10

Ethiopia has diverse agroecological zones which have contributed to the practice of different agricultural production systems by over 85% of the population. Animal husbandry forms an integral part of agricultural production in almost all ecological zones of the country.5 Pastoralists also measure to a significant proportion of the country's population. Dairy product processing and animal husbandry are very traditional. Limited reports from some parts of the country have shown the existence of bovine brucellosis.11 Transmission from animals to humans is expected due to significant animal–human contacts and consumption of raw and undercooked animal products in Ethiopia.12

Although studies have been conducted on the seroepidemiology of bovine brucellosis in different parts of Ethiopia,11,1319 only a few studies focused on humans, mainly on occupationally at-risk individuals (farmers, abattoir workers).2023 There is scarcity of studies on clinical cases.12 More studies from different perspectives, including the general population, are needed to define the burden and risk factors of human brucellosis in Ethiopia. Hence, this cross-sectional study was conducted from January to March 2014 to assess the seroepidemiology and risk factors of brucellosis among blood donors at Arba Minch Blood Bank Center located in Arba Minch town, 505 km southwest of Addis Ababa. The center is the main source of transfusion blood for eight hospitals in Gamo Gofa, Wolayta, Segen, and South Omo zones.

Donors were screened based on medical history questionnaire for chronic and acute diseases, blood pressure, weight, and qualitative hematocrit. Blood was collected into citrate-phosphate-dextrose-adenine anticoagulated blood collection bag. The leftover sample in the blood bag tube was dispensed into silicon-coated test tube (BD Vacutainer blood collection tube, Franklin Lakes, NJ). The tube was then inverted 4–6 times gently to mix the blood with clot activator in the tube and allowed to stand for 30–40 minutes for clotting at room temperature. Subsequently, the clotted blood was centrifuged at 1,300 Relative Centrifugal Force for 10 minutes, and about 1.5 mL serum sample was carefully transferred to cryotube and immediately stored in −20°C freezer until processed within a week of sample collection.

HumaTex febrile antigen test kit (Human Diagnostic, Wiesbaden, Germany) was used for primary screening. Titer determination was done according to the manufacturer's recommendations. The kit consisted of stained bacterial suspensions of B. abortus that react with antibodies to all three Brucella species pathogenic for humans (B. abortus, B. melitensis, and B. suis). The serum titer was defined as the highest dilution showing agglutination. Two experienced laboratory personnel independently read and reported serological tests. Results were recorded as positive when the readings were concordant.

Data on the risk factor for human brucellosis were collected by blood donor screening professionals through face-to-face interview using a structured questionnaire. The questions mainly focused on presence and type of domestic ruminant animals at home, consumption of unpasteurized milk and raw animal products, and extent of contact with domestic ruminant animals. Variables like age, sex, blood donation history, residence, occupation, educational level, and other related data were also recorded.

Epidemiologic and laboratory data were entered into IBM SPSS Statistics for Windows version 20 (IBM Corp, Armonk, NY) for analysis. All known and common risk factors for brucellosis were assessed for their association with the serologic screening result for brucellosis using the standard binary logistic regression analysis. For contingency tables having cell frequencies of zero, exact logistic regression using the software Stata version 12 (StataCorp LP, College Station, TX) was done to identify the association between brucellosis and the respective risk factor. Odds ratios (ORs) with 95% confidence intervals (CIs) were used as measures of the presence and strength of association between variables. P value was used to indicate the probability of obtaining the observed result or a more extreme one by chance. P values less than or equal to 0.05 were considered statistically significant.

Ethical approval for this study was obtained from the Research Review Committee of the Southern Nations, Nationalities and Peoples Region Health Bureau. Informed consent was obtained from each participant before data collection. Permission to do the research was obtained from Arba Minch Blood Bank Center.

A total of 254 donors donated blood through regular programs and outreach blood collection campaigns. Majority of the study participants were males (82.3%). The mean age of the study participants was 26 years (standard deviation = 8.26). Nearly 57% were voluntary donors and the rest were replacement donors. Most of the donors were from Arba Minch town (48.8%) and the others came from wider areas around Arba Minch town, mainly from Bonke (5.9%), Chencha (4.3%), Gerese (3.9%), and Konso (4.7%). The predominant occupational groups were students (40.6%) and farmers (27.2%) (Table 1). One hundred and thirty-two (54.5%) of the participants reported possessing domestic ruminant animals at home. Of these, 93.9% possessed cattle, followed by sheep (56.5%) and goat (52.7%).

Table 1.

Sociodemographic characteristics of the study participants, Arba Minch Blood Bank Center, Ethiopia, January–March 2014

Variables Count Percent
Age, in years (N = 243) 16–30 182 74.9
≥ 31–45 56 23.0
≥ 46 5 2.1
Sex (N = 243) Male 200 82.3
Female 43 17.7
Donors status (N = 244) Volunteer 140 57.4
Replacement 104 42.6
Residence (N = 239) AM town 124 51.9
Outskirts of AM 24 10.0
Near to AM 53 22.2
Far from AM 38 15.9
Occupation (N = 239) Student 103 43.1
Farmer 69 28.9
Merchant 11 4.6
Daily laborer 7 2.8
Pastoralist 4 1.7
Other 45 18.8
Educational level (N = 241) Illiterate 34 14.1
Write, read 12 5.0
Primary 44 18.3
Secondary 76 31.5
Higher education 75 31.1
Marital status (N = 243) Single 134 55.1
Married 109 44.9
History of blood donation (N = 244) Yes 17 6.7
No 227 93.0

AM = Arba Minch.

The overall seroprevalence of human brucellosis among the blood donors was 10.6% (27/254; 95% CI = 7.0, 14.0). For the 27 primary reactive samples, the mean titer of reactive agglutinins was 1:37 (range < 1:20–1:80) and none was reactive at the titration level equal to and above 1:160. The frequency of reactive serum at the titer of < 1:20, 1:20, 1:40, and 1:80 were 3, 10, 8 and 6, respectively. The study participants' occupation and variables related to possession of and contact with domestic ruminant animals were significantly associated with Brucella seropositivity. Being a farmer (OR = 3.68 [95% CI = 1.58, 8.58]), possession of ruminants (OR = 2.91 [95% CI = 1.12, 7.58]), history of current contact with ruminants (OR = 2.61 [95% CI = 1.04, 6.55]), and having ever assisted abortion of ruminants (OR = 2.81 [95% CI = 1.02, 7.79]) were associated with higher odds of brucellosis (Table 2).

Table 2.

Factors associated with human brucellosis, Arba Minch Blood Bank Center, Ethiopia, January–March 2014

Risk factors Category No (%) Nonreactive serum Reactive serum OR (95% CI) P value
Occupation Farmer 69 (27.2) 55 14 3.68 (1.58, 8.58) 0.003
Other 170 (66.9) 159 11 1
Possession of ruminants at home (N = 242) Yes 132 (54.5) 113 19 2.91 (1.12, 7.58) 0.028
No 110 (45.5) 104 6 1
Consumes unpasteurized milk (N = 243) yes 159 (65.4) 143 16 0.93 (0.39, 2.21) 0.874
No 84 (34.6) 75 9 1
Consumes row meat (N = 243) Yes 224 (92.2) 199 25 3.32 (0.54, + infinity) 0.233
No 19 (7.8) 19 0 1
Consumes “Dullet”* (N = 243) Yes 223 (95.9) 208 25 1.64 (0.25, + infinity) 0.661
No 10 (4.1) 10 0 1
Current contact with ruminants (N = 242) Yes 122 (50.4) 105 17 2.61 (1.04, 6.55) 0.041
No 120 (49.6) 113 7 1
Ever attended parturition (N = 243) Yes 75 (30.9) 64 11 1.89 (0.82, 4.39) 0.138
No 168 (69.1) 154 14 1
Ever encountered dystocia (N = 243) Yes 39 (16) 32 7 2.26 (0.87, 5.85) 0.093
No 204 (84) 186 18 1
Ever assisted abortion (N = 243) Yes 28 (11.5) 22 6 2.81 (1.02, 7.79) 0.046
No 215 (88.5) 196 19 1
Ever attended slaughtering (N = 241) Yes 79 (32.8) 67 12 2.05 (0.89, 4.74) 0.092
No 162 (67.2) 149 13 1

CI = confidence interval; OR = odds ratio.

*

“Dullet” is food prepared from the intestines and organs (such as liver) of cattle.

The seroprevalence of 10.6% for human brucellosis determined by this study is quite higher compared with available epidemiological and clinical studies in Ethiopia: 2.15% in a group of healthy and nonspecific febrile patients,20 3.78–5.30% among occupationally exposed individuals,2123 3–34.1% among patients with symptoms compatible with brucellosis,12 6.3% among blood donors,24 3.6% among febrile cases of unknown origin,25 and 2.6% among acute febrile cases visiting health facilities.26

Comparing the current serologic finding with reports on similar study groups (apparently healthy individuals), various levels of prevalence were noted. As such, low level of Brucella agglutinins (0.33%) with only one true positive sample (0.11%) for Brucella agglutinins was reported in one of the studies,27 and another study reported a relatively high prevalence (6.3%) with a titer of 1:80 thus revealing the importance of brucellosis in blood transfusion.25 In Mexico, a seroprevalence of 3.6% was reported among blood donors.28 It should, however, be noted that interpretation of the seroprevalence of brucellosis is made considering the serological test used, the characteristics of the study population, environmental hygiene, local prevalence of brucellosis, species of the causative agent, and other local factors. The interpretation of a positive result is also equally important. Although in the present study we considered any agglutination as positive, others have used qualitative slide agglutination titer level of 1:32 to define seropositivity.26 Furthermore, the agglutination tests that were used lack specificity. Hence, all the foregoing factors separately or in combination might explain the observed difference in seroprevalence of brucellosis between the current study and the available reports both from Ethiopia and elsewhere.

Serologic cutoff values to define recent Brucella infection also vary across geographical regions. A titration level between 1:80 and 1:160 using tube agglutination method is generally considered clinically significant. The titer of 22% of individuals in this study falls within the titer range of active infection, whereas the rest may be considered as passive infection. These passive infections may be due to previous Brucella infection or exposure to infected cattle. However, the multiscreening serological test kit used in this study has been reported to yield false-negative results in the early phase of the disease, and is affected by a prozone effect of serological tests and antibiotic treatment. In addition, serum from low or nonimmune responders may also produce false-negative results, and serological cross-reactions in cases of infection or vaccination with some strains of Vibrio cholerae, Pasteurella, Proteus OX19, and Yersinia enterocolitica serotype 9 have been reported, which may overestimate the seroprevalence of brucellosis.

More than 85% of the Ethiopian population is agrarian and animal husbandry forms an integral part of agricultural activities in almost all ecological zones. Ninety-five percent of cattle are farmed under a mixed agricultural livelihood.5 These scenarios make the population at risk of zoonotic diseases. Serological evidence suggests the existence of bovine brucellosis in Ethiopia with varying prevalence in different geographical localities: 1.66% in Sidama zone, southern Ethiopia29; 1.2% in Tigray region, northern Ethiopia16; 11% in Wuchale Jida District, central Ethiopia19; 5.1–18.6% in Shewa, central Ethiopia30; 2.9% in central Oromiya14; 0.77% in Jimma zone, west Ethiopia31; and 1.9% in a large-scale study using 2,334 cattle from 273 farms.32 Although no specific data were available from the study region on bovine brucellosis, the high seroprevalence in humans indicates bovine brucellosis might be much more common than other parts of the country. This calls for large-scale studies and stronger evidence on human and animal brucellosis in the area.

Studies focusing on brucellosis are very limited in Ethiopia. These limited studies have rarely addressed risk factors for human infection.5 The present study showed that a very close contact with domestic ruminant animals had significant association with Brucella seropositivity. In this study, most individuals had close contact with cattle and known practices that put an individual at risk of brucellosis were common. This is in conformation with the general living standard and cultural conditions in Ethiopia that inherently predispose individuals to zoonotic diseases. In addition, animal husbandry is very traditional in Ethiopia and people most often live with their animals under the same roof and health-care support for their animals is minimal. Suboptimal handling, processing, and marketing of animal and animal products for consumption are additional factors for transmission of human brucellosis. Besides, these conditions vary under different cultural/traditional setups12 and hence call for the need to study the epidemiology of human brucellosis in different localities in Ethiopia.

In conclusion, in southern Ethiopia, the risk of zoonotic transmission of brucellosis seems apparent. Farmers and those with close contact to domestic ruminant animals were found to have higher odds of Brucella seropositivity. This study implies the need to consider brucellosis a locally neglected zoonotic disease. The documented high exposure of the community to Brucella and the considerable risk of transmission should encourage screening of donors' blood for brucellosis and to consider the disease in the differential diagnosis of acute febrile illnesses. Since brucellosis is a zoonosis, the condition in animals should be equally emphasized for a comprehensive fight against this disease. Furthermore, additional epidemiologic and confirmatory studies are needed to understand the wider picture of brucellosis in southern Ethiopia.

ACKNOWLEDGMENTS

The sample collection set-up was provided by Arba Minch Blood Bank Center. We are very grateful to Tobias Renke de Wit, Henk Smits, Wondwosen Tsegaye, and Hallelujah Getachew for their important help throughout the research processes. We also remain indebted to the Blood Bank screening professionals who were involved in sample collection and blood donor interview. Behailu Besha deserves special thanks for his extra commitment to handle research activities at the sample collection sites. Participants of the study are most acknowledged for their invaluable involvement in this study. The American Society of Tropical Medicine and Hygiene (ASTMH) assisted with publication expenses.

Footnotes

Financial support: The study was conducted by a competitive small grant obtained from Arba Minch College of Health Sciences for the project package “serology of acute febrile diseases.”

Authors' addresses: Bereket Workalemahu, Medical laboratory Technology Team, Arba Minch College of Health Sciences, Arba Minch, Ethiopia, E-mail: bekicho@gmail.com. Tsegaye Sewunet, Department of Laboratory Science and Pathology, Jimma University, Jimma, Ethiopia, E-mail: tsegishs2010@gmail.com. Ayalew Astatkie, School of Public and Environmental Health, College of Medicine and Health Sciences, Hawassa University, Hawassa, Ethiopia, E-mail: ayalewastatkie@gmail.com.

References

  • 1.Pappas G, Papadimitriou P, Akritidis N, Christou L, Tsianos EV. The new global map of human brucellosis. Lancet Infect Dis. 2006;6:91–99. doi: 10.1016/S1473-3099(06)70382-6. [DOI] [PubMed] [Google Scholar]
  • 2.Ducrotoy MJ, Bertu WJ, Ocholi RA, Gusi AM, Bryssinckx W, Welburn S, Moriyon I. Brucellosis as an emerging threat in developing economies: lessons from Nigeria. PLoS Negl Trop Dis. 2014;8:e3008. doi: 10.1371/journal.pntd.0003008. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3.Swai ES, Schoonman L. Human brucellosis: seroprevalence and risk factors related to high risk occupational groups in Tanga Municipality, Tanzania. Zoonoses Public Health. 2009;56:183–187. doi: 10.1111/j.1863-2378.2008.01175.x. [DOI] [PubMed] [Google Scholar]
  • 4.Dean AS, Crump L, Greter H, Schelling E, Zinsstag J. Global burden of human brucellosis: a systematic review of disease frequency. PLoS Negl Trop Dis. 2012;6:e1865. doi: 10.1371/journal.pntd.0001865. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 5.Yohannes M, Degefu H, Tolosa T, Belihu K, Cutler R, Cutler S. Brucellosis in Ethiopia. Afr J Microbiol Res. 2013;7:1150–1157. [Google Scholar]
  • 6.Corbel MJ. Brucellosis in Humans and Animals. Geneva, Switzerland: World Health Organization; 2006. [Google Scholar]
  • 7.Rahman AK, Dirk B, Fretin D, Saegerman C, Ahmed MU, Muhammad N, Hossain A, Abatih E. Seroprevalence and risk factors for brucellosis in a high-risk group of individuals in Bangladesh. Foodborne Pathog Dis. 2012;9:190–197. doi: 10.1089/fpd.2011.1029. [DOI] [PubMed] [Google Scholar]
  • 8.John K, Fitzpatrick J, French N, Kazwala R, Kambarage D, Mfinanga GS, MacMillan A, Cleaveland S. Quantifying risk factors for human brucellosis in rural northern Tanzania. PLoS One. 2010;5:e9968. doi: 10.1371/journal.pone.0009968. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 9.Dean AS, Crump L, Greter H, Hattendorf J, Schelling E, Zinsstag J. Clinical manifestations of human brucellosis: a systematic review and meta-analysis. PLoS Negl Trop Dis. 2012;6:e1929. doi: 10.1371/journal.pntd.0001929. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 10.Godfroid J, Scholz HC, Barbier T, Nicolas C, Wattiau P, Fretin D, Whatmore AM, Cloeckaert A, Blasco JM, Moriyon I, Saegerman C, Muma JB, Al Dahouk S, Neubauer H, Letesson JJ. Brucellosis at the animal/ecosystem/human interface at the beginning of the 21st century. Prev Vet Med. 2011;102:118–131. doi: 10.1016/j.prevetmed.2011.04.007. [DOI] [PubMed] [Google Scholar]
  • 11.Berhe G, Belihu K, Asfaw Y. Seroepidemiological investigation of bovine brucellosis in the extensive cattle production system of Tigray Region of Ethiopia. Int J Appl Res Vet Med. 2007;5:65–71. [Google Scholar]
  • 12.Regassa G, Mekonnen D, Yamuah L, Tilahun H, Guta T, Gebreyohannes A, Aseffa A, Abdoel TH, Smits HL. Human brucellosis in traditional pastoral communities in Ethiopia. Int J Trop Med. 2009;4:59–64. [Google Scholar]
  • 13.Jergefa T, Kelay B, Bekana M, Teshale S, Gustafson H, Kindahl H. Epidemiological study of bovine brucellosis in three agro-ecological areas of central Oromiya, Ethiopia. Rev Sci Tech. 2009;28:933–943. doi: 10.20506/rst.28.3.1939. [DOI] [PubMed] [Google Scholar]
  • 14.Yohannes M, Tesfaye M, Hailu D, Tadele TWM. Bovine brucellosis: serological survey in Guto-Gida District, East Wollega Zone, Ethiopia. Global Veterinaria. 2012;8:139–143. [Google Scholar]
  • 15.Megersa B, Biffa D, Niguse F, Rufael T, Asmare K, Skjerve E. Cattle brucellosis in traditional livestock husbandry practice in southern and eastern Ethiopia, and its zoonotic implication. Acta Vet Scand. 2011;53:24. doi: 10.1186/1751-0147-53-24. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 16.Haileselassie M, Shewit KKM. Serological survey of bovine brucellosis in barka and arado breeds (Bos indicus) of western Tigray, Ethiopia. Prev Vet Med. 2010;94:28–35. doi: 10.1016/j.prevetmed.2009.12.001. [DOI] [PubMed] [Google Scholar]
  • 17.Teklue T, Tolosa T, Tuli G, Beyene B, Hailu B. Sero-prevalence and risk factors study of brucellosis in small ruminants in Southern Zone of Tigray Region, northern Ethiopia. Trop Anim Health Prod. 2013;45:1809–1815. doi: 10.1007/s11250-013-0439-7. [DOI] [PubMed] [Google Scholar]
  • 18.Ibrahim N, Belihu K, Lobago F, Bekana M. Sero-prevalence of bovine brucellosis and its risk factors in Jimma zone of Oromia Region, south-western Ethiopia. Trop Anim Health Prod. 2010;42:35–40. doi: 10.1007/s11250-009-9382-z. [DOI] [PubMed] [Google Scholar]
  • 19.Kebede T, Ejeta GGA. Seroprevalence of bovine brucellosis in smallholder farms in central Ethiopia (Wuchale-Jida district) Revue Méd Vét. 2008;159:3–9. [Google Scholar]
  • 20.Tibesso G, Ibrahim N, Tolosa T. Sero-prevalence of bovine and human brucellosis in Adami Tulu, central Ethiopia. World Appl Sci J. 2014;31:776–780. [Google Scholar]
  • 21.Kassahun A, Shiv P, Yilkal A, Esayas G, Gelagaye AZA. Seroprevalence of brucellosis in cattle and high risk professionals in Sidama Zone, southern Ethiopia. Ethiop Vet J. 2007;11:69–84. [Google Scholar]
  • 22.Mussie H, Tesfu K, Mulugeta T, Kelay B, Yilkal AAA. Seroprevalence of brucellosis in cattle and occupationally related human in selected sites of Ethiopia. Ethiop Vet J. 2007;11:49–65. [Google Scholar]
  • 23.Kassahun J, Yimer E, Geyid A, Abebe P, Newayeselassie B, Zewdie B, Beyene M, Bekele A. Sero-prevalence of brucellosis in occupationally exposed people in Addis Ababa, Ethiopia. Ethiop Med J. 2006;44:245–252. [PubMed] [Google Scholar]
  • 24.Ghilian R, Hekmati Moghaddam SH, Fatemi A, Eslamieh H, Dargahi M. Seroepidemiologic status of brucellosis in blood donors in Yazd, 2009. Sci J Iran Blood Transfus Org. 2011;7:196–205. [Google Scholar]
  • 25.Tolosa T, Ragassa F, Belihu K, Tizazu G. Brucellosis among patients with fever of unknown origin in Jimma University Hospital, southwestern Ethiopia. Ethiop J Health Sci. 2007;17:59–64. [Google Scholar]
  • 26.Animut A, Mekonnen Y, Shimelis D, Ephraim E. Febrile illnesses of different etiology among outpatients in four health centers in northwestern Ethiopia. Jpn J Infect Dis. 2009;62:107–110. [PubMed] [Google Scholar]
  • 27.Sofian M, Sheikholeslami M, Mahdaviani FA, Aghakhani A, Banifazl M, Eslamifar A, Sarmadian H, Deiri G, Ramezani A. Low prevalence of Brucella agglutinins in blood donors in central province of Iran. Iran J Microbiol. 2013;5:24–27. [PMC free article] [PubMed] [Google Scholar]
  • 28.Torres-Padilla JC, Lopez-Merino A, Garcia-Escamilla RM, Gutierrez-Garcia JN. Anti-Brucella antibody seroprevalence in blood donors for therapeutic ends at three blood banks of the Mexican Institute of Social Security [in Spanish] Gac Med Mex. 2004;140:391–398. [PubMed] [Google Scholar]
  • 29.Asmare K, Asfaw Y, Gelaye E, Ayelet G. Brucellosis in extensive management system of Zebu cattle in Sidama Zone, southern Ethiopia. Afr J Agric Res. 2010;5:257–263. [Google Scholar]
  • 30.Dinka HRC. Seroprevalence study of bovine brucellosis in pastoral and agro-pastoral areas of East Showa Zone, Oromia Regional State, Ethiopia. Am Eurasian J Agric Environ Sci. 2009;6:508–512. [Google Scholar]
  • 31.Tolosa T, Ragassa FKB. Seroprevalence study of bovine brucellosis in extensive management system in selected sites of Jimma Zone, western Ethiopia. Bull Anim Health Prod Afr. 2008;56:25–37. [Google Scholar]
  • 32.Asmare K, Sibhat B, Molla W, Ayelet G, Shiferaw J, Martin AD, Skjerve E, Godfroid J. The status of bovine brucellosis in Ethiopia with special emphasis on exotic and cross bred cattle in dairy and breeding farms. Acta Trop. 2013;126:186–192. doi: 10.1016/j.actatropica.2013.02.015. [DOI] [PubMed] [Google Scholar]

Articles from The American Journal of Tropical Medicine and Hygiene are provided here courtesy of The American Society of Tropical Medicine and Hygiene

RESOURCES